RHYTHM PHARMACEUTICALS CEO Keith Gottesdiener's 2018 pay jumps 130% to $3.5M
RHYTHM PHARMACEUTICALS reports 2018 executive compensation
By ExecPay News
Published: April 30, 2019
RHYTHM PHARMACEUTICALS reported fiscal year 2018 executive compensation information on April 30, 2019.
In 2018, three executives at RHYTHM PHARMACEUTICALS received on average a compensation package of $2.2M, a 72% increase compared to previous year.
Average pay of disclosed executives at RHYTHM PHARMACEUTICALS
Keith M. Gottesdiener, Chief Executive Officer, received $3.5M in total, which increased by 130% compared to 2017. 78% of Gottesdiener's compensation, or $2.8M, was in option awards. Gottesdiener also received $278K in non-equity incentive plan and $506K in salary.
Hunter C. Smith, Chief Financial Officer, received a compensation package of $1.6M, which increased by 46% compared to previous year. 61% of the compensation package, or $961K, was in option awards.
Lex H.T. Van der Ploeg, Chief Scientific Officer, earned $1.4M in 2018.
Related executives
You may also like
Source: SEC filing on April 30, 2019.